Tumour Reactions to Hypoxia

被引:39
|
作者
Voss, M. J. [1 ]
Niggemann, B. [1 ]
Zaenker, K. S. [1 ]
Entschladen, F. [1 ]
机构
[1] Univ Witten Herdecke, Inst Immunol, D-58448 Witten, Germany
关键词
Hypoxia; angiogenesis; lymphangiogenesis; neoneurogenesis; metabolic shift; cell migration; metastasis formation; ENDOTHELIAL GROWTH-FACTOR; LYMPH-NODE METASTASIS; INDUCIBLE FACTOR-I; PERINEURAL INVASION; GENE-EXPRESSION; PROGNOSTIC-SIGNIFICANCE; NEUROTROPHIC FACTORS; INDUCED MIGRATION; CANCER CELLS; FACTOR VEGF;
D O I
10.2174/156652410791317020
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Fast growing solid tumours generally lack an inner organisation, which causes the problem of a sufficient nutrient of each part of the tumour that then happens only by diffusion. The low oxygen supply leads to the activation of hypoxia-inducible factors, which regulate a plethora of genes. The reaction of tumour cells to hypoxia can be divided into two parts: On the one hand, there are signal substances, predominantly growth factors and cytokines, which provoke the vascularisation (angiogenesis), lymph vessel development (lymphangiogenesis), and the innervation (neoneurogenesis) of tumours and thus connect the tumour to structures of the environment. On the other hand, genes for intracellular proteins and receptors are regulated, which lead to changes of the tumour cell functions. Best characterised is the metabolic shift, a high anaerobic glycolytic activity and simultaneously a reduction of respiration. Furthermore, proliferation, dedifferentiation, resistance to apoptosis, and the metastatic potential are affected. With regard to the latter, we herein show that the migratory activity and velocity of PC-3 human prostate carcinoma cells significantly increase under oxygen-deprivation, which might be an explanation for the increasing number of experimental and clinical hints, that an anti-angiogenic therapy can promote the metastasis formation.
引用
收藏
页码:381 / 386
页数:6
相关论文
共 50 条
  • [41] Tissue hypoxia, tumour angiogenesis and radiation oncology
    Lartigau, E
    THERAPIE, 2001, 56 (05): : 495 - 499
  • [42] Drugs that target tumour hypoxia: The promise and the challenge
    Denny, WA
    BRITISH JOURNAL OF CANCER, 2003, 88 : S2 - S2
  • [43] Exploitation of hypoxia for tumour therapy: new approaches
    Adams, G
    Chaplin, D
    PROGRESS IN RADIO-ONCOLOGY VI, 1998, : 193 - 203
  • [44] Hypoxia and the extracellular matrix: drivers of tumour metastasis
    Gilkes, Daniele M.
    Semenza, Gregg L.
    Wirtz, Denis
    NATURE REVIEWS CANCER, 2014, 14 (06) : 430 - 439
  • [45] Hypoxia-inducible factors and tumour pathways
    Maxwell, P
    JOURNAL OF INTERNAL MEDICINE, 2004, 255 (06) : 702 - 703
  • [46] Anticancer Approaches Based on Tumour Hypoxia and Metabolism
    Pouyssegur, J.
    Chiche, J.
    Le Floch, R.
    Roux, D.
    Simon, M. P.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S30 - S30
  • [47] Tumour Hypoxia and Technetium Tracers: In Vivo Studies
    Abrantes, A. M.
    Serra, E.
    Gonoalves, C.
    Oliveiros, B.
    Laranjo, M.
    Sarmento-Ribeiro, A. B.
    Rocha-Gonsalves, A.
    Botelho, M. F.
    CURRENT RADIOPHARMACEUTICALS, 2012, 5 (02) : 99 - 105
  • [48] Survivin and tumour hypoxia in human cervical cancer
    Bache, M
    Holzapfel, D
    Kappler, M
    Holzhausen, HJ
    Taubert, H
    Dunst, J
    Hänsgen, G
    STRAHLENTHERAPIE UND ONKOLOGIE, 2005, 181 : 97 - 97
  • [49] Imaging tumour hypoxia with positron emission tomography
    I N Fleming
    R Manavaki
    P J Blower
    C West
    K J Williams
    A L Harris
    J Domarkas
    S Lord
    C Baldry
    F J Gilbert
    British Journal of Cancer, 2015, 112 : 238 - 250
  • [50] Hypoxia - A key regulatory factor in tumour growth
    Harris, AL
    NATURE REVIEWS CANCER, 2002, 2 (01) : 38 - 47